INTRODUCTION
Protein represent a rapidly expanding class of therapeutic molecules (Strohl and Knight, 2009 ), but their actions are limited primarily to extracellular targets (Fischer, 2007; Johnson et al., 2011) because the size and composition of most polypeptides and peptide mimetics preclude their uptake into mammalian cells (Luedtke et al., 2003) . It has been known for over 40 years that addition of cationic charges to a peptide or protein can aid transport into cells (Ryser and Hancock, 1965) , and many reports have documented the utility of appending basic sequences derived from the HIV transactivator of transcription (Tat) (Zhou et al., 2009) , D. melanogaster Antennapedia (Thé odore et al., 1995) , or simply polyarginine (for example, Arg 8 ) (Futaki et al., 2001 ) to peptides or small molecules (Wender et al., 2008) to increase their cytoplasmic access. Certain highly positively charged proteins (Cronican et al., 2011) and toxins (Johannes and Popoff, 2008) and certain peptide mimetics (Verdine and Hilinski, 2012; White et al., 2011 ) also possess cell-penetrating properties, but it remains unknown how one can leverage these examples to control the precise entry pathway or enhance the uptake of designed peptides or mimetics.
Two contrasting mechanisms have been proposed for the cytosolic entry of cationic proteins and related molecules. The first (ion-pair-guided passive diffusion) posits that guanidinium side chains on the polypeptide form hydrogen bonds with cellsurface phospholipids creating neutral ion pairs that passively diffuse across the plasma membrane (Rothbard et al., 2005) . The second model (endosomal release) asserts that endocytosis is a major portal through which cationic polypeptides and peptide mimetics enter the cell (Fischer, 2007) . Previous investigations have attempted to distinguish between these two models by blocking endocytosis via thermal (Derossi et al., 1996) , pharmacologic (Wadia et al., 2004; Fischer et al., 2004) , or genetic means (Ter-Avetisyan et al., 2009) . The interpretation of these experiments is complicated, however, by differences in protein/polypeptide concentration and analytical method. For example, incubation of living cells with cationic proteins/polypeptides at concentrations R10 mM leads to the formation of nucleation zones (Duchardt et al., 2007) that transiently disrupt membranes (Palm-Apergi et al., 2009) , causing the spontaneous release of peptide into the cytosol. Incubation of cells at lower concentrations (%5 mM) of peptide, in the presence of drugs that inhibit endocytosis, prevents cytoplasmic access (Wadia et al., 2004) , implying that at low concentrations, the molecules studied cannot diffuse through the plasma membrane. Moreover, the many studies using microscopy to examine cells fixed by treatment with formaldehyde or methanol must be reevaluated in light of evidence that the fixation process can release fluorescently labeled peptides from endosomes (Belitsky et al., 2002 and Richard et al., 2003) , an artifact not observed during microscopic examination of living cells. Finally, the high-intensity light used during microscopy can itself facilitate the redistribution of fluorescently labeled peptides from endosomes to cytoplasm (Maiolo et al., 2004) . Thus, whether, when, and how these cationic molecules escape endocytic vesicles to access the cytosol remain unanswered questions.
Attempts to identify the structural determinants of cell permeability are complicated by the above experimental details, as well as by the fact that neither Tat nor Arg 8 possesses a defined fold. Miniature proteins are a family of small (36 aa), well-folded polypeptides that adopt a characteristic hairpin fold consisting of axially packed a-and PPII helices (Blundell et al., 1981; Hodges and Schepartz, 2007) . Miniature proteins identified through both rational design (Zondlo and Schepartz, 1999; Zellefrow et al., 2006) and molecular evolution (Chin and Schepartz, 2001; Rutledge et al., 2003; Golemi-Kotra et al., 2004; Gemperli et al., 2005) can modulate protein function by inhibiting protein interactions (Rutledge et al., 2003; Gemperli et al., 2005) ; both loss-offunction and gain-of-function activities have been observed (Golemi-Kotra et al., 2004; Gemperli et al., 2005; Zellefrow et al., 2006) . We reported previously that minimally cationic miniature proteins containing between 2 and 6 arginine residues embedded within the a-or PPII helix were taken up by mammalian cells in culture more efficiently than Tat or Arg 8 (Daniels and Schepartz, 2007; Smith et al., 2008) . In this report we investigate whether, when, and how miniature proteins containing arginine access the cytoplasm.
To learn more about the structural determinants of cytoplasmic access, we designed a set of miniature proteins that differed in the number and density of a-helical arginine side chains and tracked their passage into the cell. Using low concentrations (1 mM) of fluorophore-conjugated variants, we found that a minimum of four a-helical arginines was required for cell uptake, and that uptake was enhanced when the arginines were clustered on the same a-helix face. Next, a novel and rapid assay for evaluating cytoplasmic access revealed that of four cationic miniature proteins taken up by cells, only one reaches the cytosol. This miniature protein, which we named 5.3, possesses a distinct array of five dispersed a-helical arginines. Live-cell confocal microscopy revealed that rhodamine-labeled 5.3 (5.3 R ) is taken up by an endocytic pathway that includes Rab5+ and Rab7+ endosomes. This pathway is shared by Tat, Arg 8, and cationic miniature proteins that do not reach the cytosol. However, for 5.3, Tat, or Arg 8 to gain cytosolic access, active endocytosis and endosomal acidification were required. We find further that unlike Tat or Arg 8 , which require vesicle maturation beyond the Rab5+ stage, miniature protein 5.3 accesses the cytosol by crossing specific membrane regions present in early Rab5+ endosomes. Finally, grafting the arginine array present in 5.3 into a well-folded zinc finger domain (Krizek et al., 1991) successfully endowed this domain with the trafficking properties of 5.3. These experiments demonstrate that discrete arginine arrangements embedded within a well-folded protein can direct cytosolic access by facilitating both efficient uptake and early endosomal escape.
RESULTS

Miniature Protein Design
To examine the effect of charge density and orientation on cell uptake, we prepared eight miniature proteins containing between one and six arginine residues at various positions on the solvent-exposed a-helical surface of the hairpin fold. These molecules also contained two arginines near the C terminus ( Figure 1A ). Seven of these cationic miniature proteins were characterized by circular dichroism (CD) spectra at 37 C that were virtually indistinguishable from that of the parent molecule lacking additional arginines, aPP (Figure S1A available online). The CD spectra of six were temperature-dependent with cooperative transitions between 49 C and 67 C (Figures S1B and S1C), suggesting that they each retained a stable and characteristic hairpin fold (Hodges and Schepartz, 2007) . Miniature protein 6.3, containing the greatest number of arginine substitutions (six), showed reduced ellipticity at 222 nm and 208 nm (Figure S1A) , along with a reduced T m of 33 C (Figures S1B and S1C); 6.3 was not studied further. For the remaining molecules, these CD data suggest that arginine substitution does not significantly alter miniature protein secondary structure, and that Figure 1B is a reasonable representation of the arginine sidechain arrangement in miniature proteins 2.1, 2.2, 3.2, 4.2, 4.3, 5.2, and 5.3.
Cell Uptake
Initially we used flow cytometry to assess the influence of arginine number and orientation on miniature protein uptake. In preliminary studies, we evaluated molecules labeled with fluorescein on their C-termini (as denoted with superscript F). To ensure that our experiment measured miniature proteins that had entered cells, we included a trypsin wash just before analysis via flow cytometry. Figure 1C ). We therefore chose to focus on miniature proteins showing significant uptake and confirmed these results by synthesizing analogs labeled instead with tetraethyl rhodamine sulfate (denoted with superscript R), a dye with several desirable properties, including resistance to photobleaching and an emission spectrum unaffected by pH changes and far from the autofluorescence spectrum of cells (Ferná ndezSuá rez and Ting, 2008) . As found for miniature proteins labeled with fluorescein, rhodamine-labeled miniature proteins containing four or five a-helical arginines were taken up efficiently, in some cases (5.2 R and 5.3 R ) more efficiently than Tat R or Arg 8 R ( Figure 2A ). Because previous studies have shown that cell-penetrating peptides, including Tat and Arg 8 , bind to cell-surface proteoglycans (Payne et al., 2007) , we verified that trypsin treatment removed miniature proteins that were bound to the cell surface. Peptides and proteins that enter the cell are inaccessible to trypsin added to the culture media (Frankel and Pabo, 1988) . Therefore, we arrested membrane traffic by incubating cells at 4 C (Hanover et al., 1984; Vonderheit and Helenius, 2005) C, trypsin treatment decreased the fluorescent signal between 77% and 89% ( Figure 2B ). These data confirm that at 4 C, incubation of cells with 1 mM cationic miniature protein leads to little if any cell uptake, and confirms that the vast majority of material bound to the cell surface is degraded and/or effectively removed by trypsin treatment. Comparison of the uptake of rhodamine-and fluorescein-labeled miniature proteins ( Figure 2C ) shows that cell uptake depends on arginine density: miniature proteins containing four arginine residues clustered on two helical faces were taken up more efficiently than those containing four arginines on three helical faces (Figures 1C, 2A, and 2C) . Molecules containing five a-helical arginines were taken up to a similar extent, irrespective of density, revealing that among these molecules the impact of arginine arrangement was smaller. Consistent with our previous work (Smith et al., 2008) , the cationic miniature proteins 5.2 R and 5.3 R are taken up with an efficiency R2-fold better than that of Tat or Arg 8 , despite the fact that they possess twice the mass and fewer (7 rather than 8) positive charges.
Cationic Miniature Proteins Traffic First into Endocytic Vesicles
To better understand the uptake pathway, we treated HeLa cells with rhodamine-labeled miniature proteins in the presence of transferrin labeled with AlexaFluor-488 (Tf 488 ) and quantified fluorescence overlap using confocal microscopy. Transferrin is rapidly internalized from the plasma membrane into endocytic vesicles (Hanover et al., 1984; Lakadamyali et al., 2006) Figure 2F ). Additional experiments to assess whether peptide trafficking was affected by fluorophore identity confirmed that rhodamine-and fluorescein-labeled variants of cationic miniature proteins, as well as Tat and Arg 8 , traffic together within cells, as indicated by highly correlated rhodamine and fluorescein intensities (R > 0.6, p < 1 3 10 À10 ; Figure S2 ).
Certain Cationic Miniature Proteins Reach the Cytoplasm
Polypeptides and peptide mimetics showing cellular uptake by flow cytometry may remain trapped in endosomes and fail to reach the cytosol (Yu et al., 2011 and Maiolo et al., 2004) . Previous assays for the cytosolic localization of peptide-or peptoid-dexamethasone (Dex) conjugates exploited the interaction of the Dex-labeled molecule with the ligand-binding domain of the cytosolic glucocorticoid receptor (GR), which led eventually to the transcription of luciferase and its detection in cell lysates 40-48 hr later (Yu et al., 2005) . Recognizing that treatment of cells with Dex leads to rapid (15 min) nuclear accumulation of a GR-green fluorescent protein fusion (GR-GFP) (Carey et al., 1996) , we asked whether microscopy could provide a rapid assay for cytosolic localization by revealing the nuclear accumulation of GR-GFP in the presence of peptide-Dex conjugates.
To test this hypothesis, HeLa cells transiently transfected with GR-GFP were incubated for 30 min with between 0 and 10 mM Dex ( Figure 3A and Figure S3A ). When Dex was absent from the incubation media, these cells exhibited GFP signal throughout the cytoplasm and the nucleus ( Figure 3A) . Addition of between 3 nM and 10 mM Dex led to a dose-dependent decrease in the cytosolic GFP signal and a concomitant increase in the nuclear GFP signal ( Figure S3A ). We quantified these changes using the automated image processing package CellProfiler (Carpenter et al., 2006) to measure the ratio of the median GFP signal in the nucleus to the median signal within a 2 mm region surrounding the region of cytosol (the ''translocation ratio'' [TR]; Figure 3B ). TR values near 1 indicate equivalent intensity between the nucleus and the surrounding region. Treatment of HeLa cells with 1 mM Dex for 30 min resulted in an increase in the TR from 1.07 ± 0.02 to 3.93 ± 0.14 (p = 1.92 3 10 À22 , versus untreated cells, two-tailed t test), roughly 90.5%
of the value achieved with a 10-fold higher concentration (Figure 3C ). We therefore chose the lower concentration for subsequent studies. When cells transfected with GR-GFP were treated for 30 min with 1 mM aPP Dex , virtually no change in GR-GFP localization or the TR was observed (1.41 ± 0.09 versus 1.25 ± 0.04, p = 0.1473; two-tailed t test; Figures 3A and 3C ). These data are consistent with the observation that aPP R fails to enter cells and with previous results (Yu et al., 2005) showing that simply adding the Dex label does not confer upon an otherwise cell-impermeable peptide the ability to reach the cytoplasm.
We next evaluated the extent to which Dex-labeled miniature proteins, as well as Tat and Arg 8 , induce the nuclear translocation of GR-GFP ( Figures 3C and 3D) . Treatment of HeLa cells expressing GR-GFP with 1 mM 5.3
Dex for 30 min led to a large increase in TR (3.1 ± 0.1) compared to both an untreated sample (-) (p = 2. (Figures S6D-S6E ).
Analysis of cytoplasmic extracts from HeLa cells treated with Tat R or Arg 8 R also showed fluorescent material, but with retention times distinct from that of the starting material (Figures S6G and S6H) , consistent with previous observations (Palm et al., 2007) that unstructured cell-penetrating peptides can be rapidly degraded. Cytoplasmic SLO extracts contained 4.4% of the 5.3R present within whole cell extracts (comparing data in Figure S3I with Figure S6E ), while SLO extracts of HeLa cells treated with aPPR showed no detectable material (lower limit of detection = 0.5%; Figure S6D ).
Cytoplasmic Access Requires Active Endocytosis
Two limiting models have been invoked to explain the trafficking of cationic peptides and proteins across the plasma membrane and into the cytoplasm. One model invokes ion-pair-guided passive membrane diffusion (Rothbard et al., 2005) ; the other invokes endocytosis followed by endosomal release. We sought to distinguish between these models in two ways. First, we asked whether inhibitors of endocytosis block the uptake of cationic miniature proteins, their cytosolic localization, or both ( Figure 4) . Second, we confirmed that cell-membrane integrity is not disrupted by the presence of 1 mM cationic miniature protein ( Figure S4 ). To determine whether active endocytosis is required for 5.3
Dex to reach the cytoplasm, we treated HeLa cells expressing GR-GFP with inhibitors of endocytosis before and during exposure to 1 mM 5.3 Dex . Clathrin-mediated endocytosis (CME), pinocytosis, and caveolin-mediated endocytosis are dependent on dynamin (Doherty and McMahon, 2009 ), whose activity is inhibited by the small molecule dynasore (Macia et al., 2006) . Depleting cellular cholesterol by treatment with methyl-b-cyclodextrin (MbCD) also inhibits these three processes (Rodal et al., 1999) . Actin remodeling, a process inhibited by addition of Nethyl-isopropyl amiloride (EIPA) (Koivusalo et al., 2010) facilitates clathrin-coated pit formation (Doherty and McMahon, 2009 ) and is required for some dynamin-and cholesterol-independent endocytic pathways. Notably, addition of EIPA does not block the uptake of some CME ligands such as transferrin (Koivusalo et al., 2010) .
To test the involvement of these pathways in the uptake of cationic miniature proteins and peptides, we pretreated HeLa cells for 30 min with 80 mM dynasore, 5 mM MbCD, or 50 mM EIPA before adding 1 mM aPP R , 5.3 R , Tat R , or Arg 8 R for 30 min at 37 C in the presence of inhibitor. The cells were subsequently washed and visualized by confocal microscopy ( Figure 4A ). The presence of dynasore completely blocked the uptake of 5. As anticipated from the microscopy results discussed above, the cytoplasmic access of Arg 8 Dex was not decreased in the presence of MbCD. Neither EIPA nor dynasore blocked the increase in the TR calculated after treatment with Dex, but MbCD reduced this increase by 53%, presumably the result of direct complexation of free Dex by MbCD (Moya-Ortega et al., 2010). The results with Arg 8 R notwithstanding, these data support the contribution of endocytic pathways to the uptake of cationic miniature proteins and peptides, and not a model based on passive diffusion. An endosome's acidification begins almost immediately upon its scission from the plasma membrane, as its lumen no longer communicates with the surrounding media. Bafilomycin is a potent inhibitor of the vesicular ATPase (Yoshimori et al., 1991) , and its addition to culture media prevents endosomal acidification (Yoshimori et al., 1991; Fischer et al., 2004 Dex reach the cytoplasm, they fail to do so in the absence of endosome acidification. This finding further supports the model that these molecules do not penetrate the plasma membrane directly, but rather escape to the cytoplasm from acidified endocytic vesicles.
Escape to the Cytoplasm from Early Endosomes
Phospholipids present in newly formed clathrin-coated vesicles and macropinosomes undergo rapid modification resulting in the recruitment of Rab5 (Lakadamyali et al., 2006; Zoncu et al., 2009 ). Rab5 is a master regulator of endosome biogenesis (Zeigerer et al., 2012) and recruits additional cellular factors required for vesicle maintenance, fusion, and maturation, including the phosphatidyl inositol (PI) 3-OH kinase (PI3K) Vps34 (Christoforidis et al., 1999b). The resulting early endocytic compartment mixes via homotypic fusion with other Rab5+ vesicles (Stenmark et al., 1994) and delivers cargo to other cellular locales through the budding off of transport vesicles (Puthenveedu et al., 2010) or Rab conversion (Rink et al., 2005) . While some cargo (such as transferrin) is recycled to the cell surface, other cargo, such as low-density lipoprotein, epidermal growth factor (Cantalupo et al., 2001) , and several types of virus (Vonderheit and Helenius, 2005) are delivered to late endosomes, marked by Rab7, for degradation in lysosomes (Huotari and Helenius, 2011 When these cells were examined by confocal microscopy, 66% of the rhodamine signal overlapped with the signal from GFP-Rab5, confirming that 5.3 R is present in Rab5+ vesicles ( Figure 5A ). Because Rab5 vesicles rapidly deliver their cargo to downstream vesicles (Rink et al., 2005) , we also evaluated colocalization of 5.3 R with Rab7-GFP ( Figure 5C ). HeLa cells transfected with Rab7-GFP and treated with 5.3 R as above showed a large fraction (87%) of the rhodamine signal located in the Rab7-GFP compartment, confirming that 5.3 R enters both early (Rab5+) and late (Rab7+) endosomes. We found no overlap between 5.3 R , Tat R , or Arg 8 R and galT-GFP (Cole et al., 1996) , a marker of the golgi ( Figure S5 ). To test whether trafficking of 5.3 R could be arrested at the Rab5 stage, we overexpressed a GTPase-inactive Rab5 mutant, Rab5 Q79L (Stenmark et al., 1994) , that blocks delivery of cargo to late endosomes and arrests vesicle maturation (Rink et al., 2005 (Figures 5D-5I ). These data suggest that 5.3 R , Tat R , and Arg 8 R follow a shared path through Rab5+ and then Rab7+ vesicles and provide a starting point to ask which, if any, of these trafficking events are required to reach the cytoplasm. To identify the point or points along the endocytic pathway at which these three molecules escape to the cytsosol, we blocked vesicle maturation through overexpression of Rab5 Q79L -GFP and assayed for cytosolic localization using dual-color microscopy and an orthogonally labeled GR-mCherry ( Figure 5J ). The TR of untreated HeLa cells expressing Rab5 Q79L -GFP or Rab5-GFP and GR-mCherry was near unity (TR = 1.32 ± 0.07), as expected, and remained unchanged after treatment for 30 min with 1 mM aPP Dex (TR = 1.25 ± 0.04 To arrest endocytic traffic at an earlier stage, we treated cells with 200 nM wortmannin, a pharmacologic inhibitor of PI3K that blocks the maturation of Rab5+ vesicles (Christoforidis et al., 1999a) by decreasing the recruitment of Rab5 effectors that bind simultaneously to Rab5 and PI-3-phosphate-containing membranes (Zoncu et al., 2009 
Chemistry & Biology Endosomal Escape of Minimally Cationic Proteins
Increased Cytosolic Localization of Zinc Finger Proteins Modified with 5.3 Arg Motif
The results described above suggest that the arginine motif present in the aPP variant 5.3 facilitates the release of this molecule from Rab5+ endosomes into the cytosol. Notably, the regioisomer 5.2, although also decorated with five arginine side chains on the external a-helix face, is released much less efficiently (Figure 3 ). To determine whether the arginine motif present on the 5.3 a-helix is transportable, that is, whether it can promote the cytosolic localization of other a-helix-containing proteins, we turned to the zinc finger proteins, as their therapeutic potential is well known (Sera, 2009; Urnov et al., 2010) . We began with the sequence of CP1, a single zinc finger possessing high zinc ion affinity (Krizek et al., 1991) , and prepared a dexamethasone-labeled variant (ZF5.3 Dex ) whose a-helix was substituted with the arginine motif in 5.3 ( Figure 6A ), a change that neither prevented zinc binding nor significantly changed the secondary structure as measured by CD ( Figure S6A ). We next evaluated the extent to which ZF5.3
Dex induced the nuclear translocation of GR-GFP when compared with a variant lacking the arginine motif (ZF Dex ) ( Figure 6B ). Treatment of HeLa cells expressing GR-GFP with 1 mM ZF5.3
Dex for 30 min led to a large increase in TR (2.4 ± 0.09) compared to both an untreated sample (0.9 ± 0.05) and one treated with ZF Dex (1.4 ± 0.05) (p < 0.0001, ANOVA with Bonferroni post-test). Control experiments confirmed that ZF5.3 R can be recovered from cytosolic extracts of HeLa cells treated with ZF5.3 R ( Figure S3L ), and that the peptide backbone of ZF5.3 is not significantly degraded under the conditions in this assay ( Figure S6I ). As observed with 5.3, inhibition of early endocytic events with dynasore, bafilomycin, EIPA, or methyl-b-cyclodextrin reduced to background levels the increase in translocation ratios observed in the presence of ZF5.3 Dex ( Figure 6B ). Furthermore, as observed with 5.3, when cells expressing GFP-Rab5 were treated with ZF5.3 R and examined by confocal microscopy, 68% of the rhodamine channel overlapped with the signal from GFPRab5, confirming that ZF5.3 R is present in Rab5+ vesicles ( Figure 6C ). Finally, as observed with 5.3, the TR of cells treated with ZF5.3 R was unaffected when endocytic traffic was arrested by treatment with wortmannin or overexpression of dominant-negative Rab5 Q79L -GFP (Figures 6B and 6D) . Together, these data imply that the arginine motif in ZF5.3, like the arginine motif in 5.3, functions to promote endocytic uptake and release from early Rab5+ endosomes, and emphasizes the potential of helical-arginine display for modulating the escape of cationic miniature proteins and peptidomimetics from early endosomes into the cytoplasm. Although further work is necessary to evaluate how broadly the motif identified here can be applied, these results provide a structural and mechanistic framework for efficiently increasing the cell permeabilities of therapeutic peptides and proteins. We estimate that between 1% and 5% of the intracellular pool of 5.3 and ZF5.3 enters the cytosol.
DISCUSSION
The interfaces that form between and among proteins and DNA-often large, flat, and polar-do not often resemble those that bind small-molecule substrates or traditional inhibitors (Rutledge et al., 2003) . Targeting these ''undruggable'' interfaces is a task well suited to protein and peptide ligands but can only be successful if such molecules reach their cytosolic targets. Unfortunately, the very properties that endow peptide mimetics with their promise-size and polarity-are precisely those properties forbidden by Lipinski's rules (Lipinski et al., 2001) . The challenge, therefore, is to identify the determinants that guide the uptake of peptide-like molecules and the mechanisms through which they gain cytosolic access, generating a new set of rules applicable to large peptidic molecules and their mimetics. Advancing this goal has been constrained by the absence of a rapid and robust assay capable of distinguishing between peptide-like molecules that remain trapped within endosomes and those that escape into the cytosol.
Here we took advantage of developments in automated image analysis and the rapid cytoplasmic-to-nuclear translocation of the GR to develop an assay that, by monitoring nuclear accumulation of a GR-GFP fusion, reports on the cytoplasmic entry of traditionally impermeant molecules tagged with the GR ligand Dex. This assay offers advantages in both speed and cost over a first-generation assay developed by Kodadek and colleagues (Yu et al., 2005) , as it provides a readout in individual living cells within 30 min (as opposed to 48 hr) and eliminates the requirement for cell lysis or costly enzymatic substrates. With this assay, we measured differences in the cytosolic localization of four actively endocytosed miniature proteins and identified 5.3 and ZF5.3 as minimally cationic proteins whose rapid cytosolic localization is equivalent to or better than Tat and Arg 8 . Furthermore, 68 of 71 cells (96%) treated with 5.3Dex showed significant changes in GR-GFP localization, whereas only 2 of 55 cells treated with Dex-aPP (3.6%) showed increased translocation ratios, highlighting that minimally cationic protein domains containing the 5.3 motif enter the cytoplasm of most cells. The large differences in cytosolic localization among the set of closely related miniature proteins emphasize that distinct structural determinants control both endocytic uptake and endosomal release. Both 5.2 and 5.3 possess mass to charge ratios of 0.73 charge units per kDa, near the value suggested by Cronican et al. (2011) to predict cell penetrating activity, but less than +36 GFP (+1.27/kDa). Nevertheless, even among proteins with similar mass to charge ratios, uptake appears to be favored by clustered a-helical arginine side chains, whereas release requires a more dispersed arginine array.
Coupling this new assay for cytosolic localization with live-cell confocal microscopy allowed us to further clarify contrasting models for the intracellular pathway taken by cationic miniature proteins and peptides en route to the cytoplasm. At low concentrations, none of the molecules studied here crossed the plasma membrane directly. Miniature protein 5.3 and the zinc finger module ZF5.3 enter into and escape from early (Rab5+) endosomes. In contrast, Tat and Arg 8 , which are also present in Rab5+ vesicles, require delivery to downstream Rab7+ vesicles or the recruitment of Rab5 effectors in order to reach the cytoplasm (Figure 7 ). The differences in arginine/lysine number and orientation in 5.3, ZF5.3, Tat, and Arg 8 will likely affect their side chain pKa values and thus the overall charge of each molecule at any given pH. Thus, it is possible that the distinct arginine array in 5.3 and ZF5.3 favors formation of a critical protonated species within the early endosome (pH $6.5), whereas the lower pH present in lysosomes may be required to generate an equivalent state for Tat and Arg 8 . Alternatively, the distinct arginine array in 5.3 and ZF5.3 could represent an export signal for cellular machinery that has yet to be identified.
SIGNIFICANCE
Proteins and other peptidic molecules able to cross biological membranes possess promise both as therapeutics and as agents for delivery of macromolecules, such as siRNA, to the cytoplasm of target cells. In a broader sense, proteins and peptides that effectively traffic across membranes offer the potential to illuminate fundamental principles of cell biology. In this work we identified two small folded proteins, the cationic miniature protein 5.3 and the zinc finger module ZF5.3, that achieve cytosolic access through rapid internalization and efficient escape from Rab5+ endosomes. The trafficking pathway that we mapped for these molecules is similar to that taken by botulinum and anthrax toxins, which also escape from early endosomes (Simpson, 2004) . The pathways followed by Tat and Arg 8, however, resemble those of SV40 (Vonderheit and Helenius, 2005) and HIV-1 (Vidricaire and Tremblay, 2005) and require transport beyond early Rab5+ endosomes to gain cytosolic access. This difference in trafficking indicates that the ability of 5.3 and ZF5.3 to rapidly escape from early endosomes is a unique feature not shared by canonical cell-penetrating peptides, and it implies the existence of distinct signals, encodable within short peptide sequences, that favor early versus late endosomal release. Identifying these signals and understanding their mechanistic basis will illustrate how cells control the movement of endocytic cargo and may allow researchers to engineer molecules to follow a desired delivery pathway for rapid cytosolic access. Collectively, our investigations represent a starting point for the optimization of well-folded functional cell-penetrating proteins The path taken by 5.3, ZF5.3, Tat and Arg8 from the cell exterior to the cytosol begins with and requires endocytosis from the plasma membrane. 5.3, ZF5.3, Tat, and Arg8 bind to the cell surface and traffic into early endosomes, which rapidly acquire Rab5, followed by Vps34, a lipid kinase responsible for generating PI3P. Inhibition of Vps34 by Wortmannin fails to block escape of 5.3 or ZF5.3 (see Figures 5 and 6 ), indicating these molecules can escape vesicles prior to this stage. Rab5 and PI3P recruit Rab5 effectors, beginning endosome maturation. Recruitment of Rab7 leads to the formation of late endosomes (LE). The Rab5+-to-Rab7+ transition, which is blocked following transfection with Rab5Q79L, is not required for 5.3 or ZF5.3 to access the cytoplasm, but decreases the escape of Tat (see Figure 5) , suggesting Tat escapes later in the endocytic pathway. Arg8 escape is blocked by wortmannin treatment but not by transfection with Rab5Q79L, suggesting escape begins late in the Rab5 stage but prior to the Rab7 stage. Endosomes are progressively acidified, a process blocked by bafilomycin (structure shown) and required for 5.3, ZF5.3, Tat, and Arg 8 to reach the cytoplasm.
useful as pharmacologic tools and capable of modulating cytoplasmic protein function.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfections HeLa cells (ATCC, Manassas, VA) were grown in T-75 culture flasks containing Dulbecco's modified essential medium (DMEM; GIBCO Cat. #11995-065, Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum, and 100 U/ml each penicillin and streptomycin. Transient transfections were performed using Fugene 6 or XtremeGene HP (Roche, Indianapolis, IN) and protocols recommended by the manufacturer. Plasmids encoding Rab5-GFP and Rab5 Q79L -GFP were gifts from Pietro DeCamilli. A plasmid containing Rab7-GFP was a gift of Qing Zhong (plasmid #28047, Addgene, Cambridge, MA). A plasmid containing GalT-EGFP was a gift of Jeniffer Lippincott-Schwartz (Addgene plasmid #11937). A plasmid containing the glucocortcoid receptor fused to EGFP (pK7-GR-GFP) was a gift of Ian Macara (Addgene plasmid #15534).
Analysis of Surface Binding and Cell Uptake
HeLa cells grown to $90% confluency were dissociated from flasks by incubation for 15 min at 37 C with 2 ml PBS, 1 mM EDTA, and 1 mM EGTA. Cells were collected in warmed media, and aliquots (150 ml, 200,000 cells) distributed to 96 well plates. The cells were incubated at 4 C or 37 C for 10 min, 1 mM fluorescently labeled peptide was added, and incubation continued for an additional 30 min. Cells were then washed twice with DMEM + 10% fetal bovine serum and treated with trypsin (30 ml per well, 0.05%, 37 C 3 10 min) before resuspending in 300 ml PBS. Cells were analyzed by flow cytometry using an Accuri C6 flow cytometer. To confirm that trypsin treatment removed fluorescently labeled peptide remaining on the cell surface, HeLa cells were treated with 1 mM miniature protein or peptide at 4 C to inhibit endocytosis. After washing twice, the cells were then treated with trypsin (30 ml, 0.05%, 37 C 3 10 min) or PBS as a control. Cells were then resuspended in 300 ml PBS before analysis by flow cytometry. Data presented are the mean ± SEM for four biological replicates measuring the mean fluorescence intensity of 30,000 cells. Dead cells defined by forward and side scatter were excluded. 
Effects of Inhibitors on Cell Uptake
HeLa cells grown for 24 hr in glass-bottom plates were incubated with HKR buffer or HKR buffer containing 80 mM dynasore, 50 mM N-ethyl-isopropyl-amiloride, or 5 mM methyl-b-cyclodextrin for 30 min at 37 C prior to the addition of 1 mM rhodamine-labeled miniature protein or peptide (Tat and Arg 8 ). The cells were washed twice with DMEM, the nuclei labeled with Hoescht, and images acquired as described above for colocalization experiments.
GR-GFP Translocation Assay
HeLa cells transfected with pK7-GR-GFP were plated in Matrical plates as described above. To label nuclei, the media were replaced with HKR buffer containing 300 nM Hoescht 33342 and the cells were incubated for 30 min at 37 C. Cells were then treated with 150 ml HKR buffer or HKR buffer containing 1 mM dexamethasone, dexamethasone-labeled miniature protein, or dexamethasone-labeled peptides for 30 min at 37 C before epifluorescence imaging. The translocation ratio (the ratio of the median intensities of GFP in the nuclear and surrounding region) for each cell imaged was measured using CellProfiler (Carpenter et al., 2006) . For further details see Supplemental Experimental Procedures online.
To examine the effects of various inhibitors, HeLa cells transfected and plated as above were pretreated with HKR buffer containing 300 nM Hoescht and 80 mM dynasore, 50 mM N-ethyl-isopropyl-amiloride, 200 nM wortmannin, 200 nM bafilomycin, or 5 mM methyl-b-cyclodextrin for 30 min at 37 C, after which 1 mM dexamethasone, dexamethasone-labeled miniature protein, or dexamethasone-labeled peptide was added for an additional 30 min at 37 C. Cells were then analyzed as described above.
To evaluate the requirement of Rab5 activity for the ability of peptides to reach the cytoplasm, HeLa cells were transfected with pGR-mCherry and either Rab5-EGFP or Rab5 Q79L -EGFP for 24 hr before treatment with dexamethasone or dexamethasone-labeled miniature proteins or peptides and imaging as described above. Cotransfected cells expressing Rab-GFP fusions and pGR-mCherry were identified via their characteristic pattern of green and red fluorescence. The translocation ratio was determined using median values of mCherry fluorescence within the nucleus and surrounding region using CellProfiler.
Statistical Analysis
Comparisons within groups were made using ANOVA. Pairwise comparisons within groups were made using Bonferroni's post-test after finding a significant difference using ANOVA. P values are corrected using Bonferroni's method (Shaffer, 1995) so that the family-wise error rate is 0.05. Otherwise, comparisons were made using a two-tailed t test.
Supplemental Experimental Procedures
Supplemental Experimental Procedures containing additional descriptions of materials, polypeptide synthesis and characterization, pGR-mCherry vector construction, circular dichroism analysis, and image acquisition and analysis may be found online.
SUPPLEMENTAL INFORMATION
Supplemental Information contains six figures, one table, and Supplemental Experimental Procedures and can be found with this article online at http:// dx.doi.org/10.1016/j.chembiol.2012.05.022.
